[go: up one dir, main page]

UA87117C2 - Применение пептидных соединений для лечения центральной невропатической боли - Google Patents

Применение пептидных соединений для лечения центральной невропатической боли

Info

Publication number
UA87117C2
UA87117C2 UAA200605953A UAA200605953A UA87117C2 UA 87117 C2 UA87117 C2 UA 87117C2 UA A200605953 A UAA200605953 A UA A200605953A UA A200605953 A UAA200605953 A UA A200605953A UA 87117 C2 UA87117 C2 UA 87117C2
Authority
UA
Ukraine
Prior art keywords
central
treatment
peptide compounds
neuropatic pain
pain
Prior art date
Application number
UAA200605953A
Other languages
English (en)
Ukrainian (uk)
Inventor
Томас Штьор
Original Assignee
Шварц Фарма Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Шварц Фарма Аг filed Critical Шварц Фарма Аг
Publication of UA87117C2 publication Critical patent/UA87117C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Данное изобретение касается применения пептидных соединений для лечения центральной невропатической боли.
UAA200605953A 2003-12-02 2004-12-02 Применение пептидных соединений для лечения центральной невропатической боли UA87117C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03027742A EP1537862A1 (en) 2003-12-02 2003-12-02 Novel use of peptide compounds for treating central neuropathic pain

Publications (1)

Publication Number Publication Date
UA87117C2 true UA87117C2 (ru) 2009-06-25

Family

ID=34442948

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200605953A UA87117C2 (ru) 2003-12-02 2004-12-02 Применение пептидных соединений для лечения центральной невропатической боли

Country Status (4)

Country Link
EP (1) EP1537862A1 (ru)
CN (1) CN100496476C (ru)
UA (1) UA87117C2 (ru)
ZA (1) ZA200603097B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1243262E (pt) 2001-03-20 2006-10-31 Sanol Arznei Schwarz Gmbh Nova utilizacao de uma classe de compostos peptideos para o tratamento da dor inflamatoria nao neuropatica
ES2185606T3 (es) 2001-03-21 2003-05-01 Sanol Arznei Schwarz Gmbh Nuevo uso de una clase de compuestos peptidicos para tratamiento de la alodinia u otros tipos diferentes de dolor cronico o fantasma.
ATE428413T1 (de) 2003-12-02 2009-05-15 Sanol Arznei Schwarz Gmbh Neue verwendung von peptidverbindungen zur behandlung ovn zentralen neuropathischen schmerzen
CN1950101B (zh) 2004-04-16 2011-03-30 舒沃茨药物股份公司 肽化合物用于预防和治疗慢性头痛的用途
EP1604655A1 (en) 2004-06-09 2005-12-14 Schwarz Pharma Ag Novel use of peptide compounds for treating pain in trigeminal neuralgia
EP1781276B1 (en) 2004-08-27 2010-06-23 UCB Pharma GmbH Use of peptide compounds for treating bone cancer pain, chemotherapy- and nucleoside-induced pain
PT2462990E (pt) 2006-06-15 2014-04-02 Ucb Pharma Gmbh Composição farmacêutica com efeito anticonvulsivo sinergístico
CN101466390B (zh) 2006-06-15 2014-03-12 优时比制药有限公司 用于治疗难治性癫痫持续状态的肽类化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849737A (en) * 1995-04-14 1998-12-15 The Regents Of The University Of California Compositions and methods for treating pain
DE60127459T2 (de) * 2000-08-25 2007-07-12 Research Corp. Technologies, Inc., Tucson Verwendung von aminosäurehaltigen Antikonvulsiva zur Behandlung von Schmerz
ES2185606T3 (es) * 2001-03-21 2003-05-01 Sanol Arznei Schwarz Gmbh Nuevo uso de una clase de compuestos peptidicos para tratamiento de la alodinia u otros tipos diferentes de dolor cronico o fantasma.

Also Published As

Publication number Publication date
EP1537862A1 (en) 2005-06-08
CN100496476C (zh) 2009-06-10
ZA200603097B (en) 2007-06-27
CN1882325A (zh) 2006-12-20

Similar Documents

Publication Publication Date Title
NO20063064L (no) Ny anvendelse av peptidforbindelser for behandling av sentralneurotisk smerte
SG149063A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
TW200626068A (en) Active compounds for seed treatment
ZA200801253B (en) Novel use of peptide compounds for treating muscle pain
CY1105082T1 (el) Χρηση της φλιβανσepινης στην αγωγη διαταραχων της σεξουαλικης επιθυμιας
TW200800976A (en) New compounds for the treatment of neurological, psychiatric or pain disorders
UA83194C2 (ru) Производные пиримидина и их применение как модуляторов св2
ATE389395T1 (de) Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson
UA85559C2 (en) Aminobenzophenone compounds
MXPA05011233A (es) Vectores peptidicos.
TW200701977A (en) Novel use of peptide compounds for treating pain in painful diabetic neuropathy
GB0329874D0 (en) Compounds useful for the treatment of diseases
WO2004091490A3 (en) Somatostatin-dopamine chimeric analogs
UA85471C2 (ru) Применение оксикодона для лечения висцеральной боли
UA87117C2 (ru) Применение пептидных соединений для лечения центральной невропатической боли
MXPA05011699A (es) Inhibidores de la bomba de protones para el tratamiento de trastornos del abdomen inferior.
GB0207653D0 (en) Methods of using lamellar bodies for therapeutic purposes
WO2004021992A3 (en) Delivery of therapeutics to the brain and spinal cord
ATE536874T1 (de) Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen
EA200600115A1 (ru) Производные 2-аминобензойной кислоты
EP1436279A4 (en) CHEMICAL COMPOUNDS
ATE423780T1 (de) Makrozyclen zur behandlung von krebserkrankungen
MXPA04004757A (es) Uso de una ascomicina para el tratamiento de blefaritis.
ATE431348T1 (de) Thiaepothilone zur behandlung von krebserkrankungen
IS8498A (is) Notkun katepsín K tálma til að meðhöndla alvarlega beintapssjúkdóma